The FDA has granted priority review for the companyâs application to expand the drugâs approved uses to include those with genotype 1b and compensated cirrhosis, without the need for ribavirin. Viekira Pak was approved in December 2014 to treat genotype 1 of hep C, including those with compensated cirrhosis.
The number of U.S. students who studied abroad for academic credit increased by three percent to 283,332 students in 2011/12, a higher rate of growth than the one percent increase the previous year.
Between 2004 and 2014, enrollment increased 17 percent, from 17.3 million to 20.2 million. The number of full-time students rose 17 percent between 2004 and 2014, while the number of part-time students rose 16 percent.